Publications

  1. Thakare V. N., Patel B. M. Potential targets for the development of novel antidepressants: Future perspectives. CNS & Neurological Disorders - Drug Targets March 2015 14(2): 270-281 [Impact factor 3.298]
  2. Rayabarapu N., Patel B. M. Beneficial role of tamoxifen in isoproterenol induced myocardial infarction. Canadian Journal of Physiology and Pharmacology October 2014 92(10): 849-857 [Impact Factor 1.546]
  3. Patel B. M., Bhadada S. V. Type 2 diabetes induced cardiovascular complications: Comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril. Clinical and Experimental Hypertension August 2014 36(5): 340-347 [In-press] [Impact Factor 1.292]
  4. Patel B. M., Raghunathan S., Porwal U. Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus. European Journal of Pharmacology April 2014 728: 128-134 [Impact Factor 2.516]
  5. Patel B. M., Desai V. J. Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy. Pharmacological Reports March-April 2014 66(2): 264-272  [Impact Factor 2.5]
  6. Patel M.M., Shah P. J., Patel B. M. Insights of biosimilars through SWOT analysis. Expert Opinion on Biological Therapy February 2014, 14(2): 139-144 [Impact Factor 3.345].
  7. Raghunathan S., Tank P., Bhadada S. V., Patel B. M. Evaluation of Buspirone on Streptozotocin induced Type 1 Diabetes and its associated complications. BioMed Research International January 2014, 2014: 9 pages Article ID 948427 (doi: 10.1155/2014/948427) [Impact Factor 2.88]
  8. Patel B. M., Damle D. Combination of telmisartan with cisplatin controls oral cancer cachexia in rats. BioMed Research International December 2013, 2013: 10 pages Article ID 642848 [Impact Factor 2.88]
  9. Mehta A. A. The choice of anti-hypertensive agents in diabetic subjects. Diabetes and Vascular Disease Research September 2013, 10(50): 385-396 [Impact Factor 2.59]
  10. Patel B.M., Kakadiya J., Goyal R.K., Mehta A.A. Effect of spironolactone on cardiovascular complications associated with type-2 diabetes in rats. Experimental and Clinical Endocrinology & Diabetes August 2013; 121(08): 441-447 [Impact Factor 1.826]
  11. Goyal B. R., Mehta A. A. Diabetic cardiomyopathy: Pathophysiological mechanisms and cardiac dysfunction. Human and Experimental Toxicology June 2013, 32(6): 571-590 [Impact Factor 1.772]
  12. Raghunathan S, Patel B.M. Therapeutic implications of small interfering RNA in cardiovascular diseases. Fundamental and Clinical Pharmacology February 2013, 27(1):1-20 [Impact Factor 2.372]
  13. Patel B. M., Mehta A. A. Aldosterone And Angiotensin: Role In Diabetes And Cardiovascular Diseases. European Journal of Pharmacology December 2012, 697(1-3): 1-12 [Impact Factor 2.516]
  14. Patel B.M., Agarwal S.S., Bhadada SV. Perindopril protects against streptozotocin induced hyperglycemic myocardial damage/alterations. Human and Experimental Toxicology November 2012, 31(11): 1138-1149 [Impact Factor 1.772]
  15. Goyal B. R., Mehta A. A. Beneficial role of spironolactone, telmisartan and their combination on isoproterenol induced cardiac hypertrophy. Acta Cardiologica January-February 2012, 67(2):203-211 [Impact Factor 0.65]
  16. Goyal B. R., Parmar K, Goyal R. K., Mehta A. A.  Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type-2 diabetic rats. Pharmacological Reports. July-August 2011, 63(4):956-966 [Impact Factor 2.5]
  17. Goyal B.R., Patel M.M., Bhadada S.V. Comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril on diabetes induced  cardiovascular complications in type 1 diabetes in rats. International Journal of Diabetes and Metabolism. April 2011, 19(1): 11-18
  18. Bhadada S.V., Patel B.M., Mehta A.A., Goyal R.K. β3 Receptors: Role in cardiometabolic disorders. Therapeutic Advances in Endocrinology and Metabolism. April 2011, 2(2): 65-79.
  19. Bhadada S.V., Goyal B.R., Patel M.M. Angiogenic targets for potential disorders. Fundamental and Clinical Pharmacology. February 2011, 25(1):29-47 [Impact Factor 2.372]
  20. Goyal B. R., Solanki N, Goyal R. K., Mehta A. A. Investigation into the cardiac effects of spironolactone in the experimental model of type 1 diabetes. Journal of Cardiovascular Pharmacology. December 2009, 54(6): 502-509 [Impact Factor 2.826]
  21. Goyal B. R., Goyal R. K., Mehta A. A. Investigation into the mechanism of anti-asthmatic action of Moringa oleifera. Journal of Dietary Supplements November 2009, 6(4): 313-327
  22. Goyal B.R., Patel M.M., Soni M.K.., Bhadada S.V. Therapeutics opportunities of small interfering RNA. Fundamental and Clinical Pharmacology. August 2009, 23(4): 367-386. [Impact Factor 2.372]
  23. Mehta A. A., Mahajan S. G., Goyal B. R., Goyal R. K. Classification of herbal antiasthmatics based on mechanism of action and chemical constituents. Phytopharmacology and Therapeutic values. In: Recent Progress in Medicinal Plants eds. Singh V. K.,  Govil J. N. 2009: 281-314
  24. Mansuri M., Goyal B. R., Sheth J, Upadhyay M, Goyal R. K. Effect of long term treatment of aqueous extract of Enicostemma littorale in Type 2 diabetic patients. Oriental Pharmacy and Experimental Medicine. March 2009, 9(1): 39-48.
  25. Patel M. M., Goyal B. R., Bhadada S.V., Bhatt J.S., Amin A. F. Getting into the brain: Approaches for enhancing brain drug delivery. CNS Drugs January 2009, 23(1): 35-58 [Impact Factor 4.54]
  26. Goyal B. R., Goyal R. K., Mehta A. A. Beneficial role of Acyranthes aspera in Toulene-Di-Isocyanate induced occupational asthma in rats. The Open Natural Products Journal  2008, 1: 44-49
  27. Goyal B. R., Goyal R. K., Mehta A. A. Investigation into the mechanism of anti-asthmatic action of Lepidium sativum. Oriental Pharmacy and Experimental Medicine. September 2008, 8(3): 286-294
  28. Goyal B. R., Mesariya P., Goyal R. K., Mehta A. A. Effect of telmisartan on cardiovascular complications associated with STZ-diabetic rats. Molecular and Cellular Biochemistry. July 2008, 314(1-2): 123-131 [Impact Factor 1.764]
  29. Goyal B. R., Agrawal B. B., Goyal R. K., Mehta A. A. Phyto-pharmacology of Moringa oleifera. Natural Product Radiance. July-August 2007, 6(4): 347-353
  30. Goyal B. R., Agrawal B. B., Goyal R. K., Mehta A. A. Pharmacological classification of herbal anti-asthmatics. Oriental Pharmacy and Experimental Medicine. March 2007, 7(1):11-25
  31. Goyal B. R., Goyal R. K., Mehta A. A. Phyto-pharmacology of Achyranthes aspera: A review. Pharmacognosy reviews. Jan-May 2007, 1(1): 143-150

Books

  1. Author of the book “Practicals in Organic and Medicinal Chemistry”, Second Edition. B. S. Shah Prakashan
  2. Author of the book “Practicals in Pharmaceutical Analysis –I (Non-Instrumental and Instrumental methods)”, First Edition. B. S. Shah Prakashan

 

 

 


Bhoomika Mayur Patel

Assistant Professor

 

  • : +91-79-27661568

  • DEPARTMENTDepartment of Pharmacology
    Institute of Pharmacy
    Nirma University
  • COUNTRY INDIA